| scholarly article | Q13442814 |
| P2093 | author name string | Gang Chen | |
| Brigitte T Huber | |||
| Natalie Sutkowski | |||
| German Calderon | |||
| P2860 | cites work | Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice | Q24524255 |
| Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module | Q24675538 | ||
| Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen | Q27731278 | ||
| Virus-encoded superantigens | Q28776748 | ||
| The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1. | Q30167565 | ||
| Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity | Q30452167 | ||
| The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo | Q33604616 | ||
| Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors | Q33866046 | ||
| Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome | Q33928303 | ||
| Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity | Q34098891 | ||
| Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution | Q34101407 | ||
| Immortalization of human primary B lymphocytes in vitro with DNA | Q34160976 | ||
| Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells | Q34366291 | ||
| LMP1 structure and signal transduction | Q34415978 | ||
| Construction of large DNA segments in Escherichia coli | Q34502907 | ||
| Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry | Q34979001 | ||
| Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference | Q35129086 | ||
| Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells | Q35575723 | ||
| Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. | Q35829475 | ||
| Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. | Q35832104 | ||
| Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation | Q35891360 | ||
| Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain | Q35891377 | ||
| Endogenous superantigen expression is controlled by mouse mammary tumor proviral loci | Q36230541 | ||
| Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development | Q36231451 | ||
| An Epstein-Barr virus-associated superantigen | Q36367270 | ||
| Epstein-Barr virus recombinants from overlapping cosmid fragments | Q36655212 | ||
| Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus | Q36791391 | ||
| Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. | Q36801839 | ||
| Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 | Q36806063 | ||
| Polyadenylation at correct sites in genome RNA is not required for retrovirus replication or genome encapsidation | Q36829761 | ||
| Superantigens: mechanism of T-cell stimulation and role in immune responses | Q37105213 | ||
| A method for production of antibodies to human T-cell receptor beta-chain variable regions | Q37596850 | ||
| Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses | Q37737223 | ||
| The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. | Q38301679 | ||
| A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. | Q39736828 | ||
| All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. | Q40044497 | ||
| Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains | Q40129920 | ||
| Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region | Q40142296 | ||
| Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction | Q40563936 | ||
| Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen | Q40773245 | ||
| Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. | Q40793575 | ||
| Interferon alpha activates the tyrosine kinase Lyn in haemopoietic cells. | Q41032505 | ||
| Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. | Q41063703 | ||
| Regulation of Epstein-Barr virus latency by latent membrane protein 2. | Q41125684 | ||
| Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus | Q41976287 | ||
| Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes | Q43679392 | ||
| Role of Stat5 in type I interferon-signaling and transcriptional regulation | Q44538997 | ||
| Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals | Q44664210 | ||
| Mechanism of transduction by retroviruses | Q44823635 | ||
| A maternally inherited superantigen encoded by a mammary tumour virus | Q44936887 | ||
| Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma | Q45736315 | ||
| Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa | Q45781476 | ||
| New Epstein–Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma | Q45800799 | ||
| Epstein-Barr virus latent gene expression during the initiation of B cell immortalization | Q45845786 | ||
| Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes | Q45855720 | ||
| The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B | Q45876441 | ||
| Isolation and localization of an IDDMK1,2-22-related human endogenous retroviral gene, and identification of a CA repeat marker at its locus | Q47926917 | ||
| An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. | Q53541156 | ||
| Multiple binding sites for bacterial superantigens on soluble class II MHC molecules | Q56922183 | ||
| Residues of the variable region of the T-cell-receptor β-chain that interact with S. aureus toxin superantigens | Q56922307 | ||
| Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice | Q59058079 | ||
| The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression | Q64377884 | ||
| Recombinant adenovirus coexpressing covalent peptide/MHC class II complex and B7-1: in vitro and in vivo activation of myelin basic protein-specific T cells | Q64379656 | ||
| Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes | Q77470217 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| membrane protein | Q423042 | ||
| superantigen | Q772950 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 7852-7860 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen | |
| P478 | volume | 78 |
| Q36509873 | A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology |
| Q52602550 | Absence of interaction between porcine endogenous retrovirus and porcine cytomegalovirus in pig-to-baboon renal xenotransplantation in vivo. |
| Q27011469 | Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis |
| Q37429555 | B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity |
| Q37101134 | Chimerically fused antigen rich of overlapped epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a potential vaccine and diagnostic agent |
| Q37625571 | Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus |
| Q39907058 | EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. |
| Q90286997 | Endogenous Avian Leukosis Virus in Combination with Serotype 2 Marek's Disease Virus Significantly Boosted the Incidence of Lymphoid Leukosis-Like Bursal Lymphomas in Susceptible Chickens |
| Q40204275 | Endogenous retroviral sequences in the human genome can play a physiological or pathological role |
| Q38241314 | Endogenous retrovirus-K and nervous system diseases |
| Q36687211 | Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors? |
| Q44539402 | Environmental stress increases variability in the expression of dental cusps |
| Q34227303 | Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response |
| Q28082701 | Epstein-Barr virus latent genes |
| Q34228703 | Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis |
| Q34427836 | Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis |
| Q40739968 | Expression of the env gene from the avian endogenous retrovirus ALVE and regulation by miR-155. |
| Q40522596 | Expression patterns of endogenous avian retrovirus ALVE1 and its response to infection with exogenous avian tumour viruses |
| Q40649135 | Gene sharing between Epstein-Barr virus and human immune response genes |
| Q102059098 | High levels of LINE-1 transposable elements expressed in Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma |
| Q52363776 | Human Endogenous Retroviruses and Their Putative Role in the Development of Autoimmune Disorders Such as Multiple Sclerosis. |
| Q36497719 | Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease |
| Q27010373 | Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice? |
| Q26776132 | Inside the Envelope: Endogenous Retrovirus-K Env as a Biomarker and Therapeutic Target |
| Q38885663 | Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection |
| Q35018133 | Natural anti-CCR5 antibodies in HIV-infection and -exposure |
| Q92438418 | Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma |
| Q21563460 | Repeated recruitment of LTR retrotransposons as promoters by the anti-apoptotic locus NAIP during mammalian evolution |
| Q34015827 | The murine gammaherpesvirus immediate-early Rta synergizes with IRF4, targeting expression of the viral M1 superantigen to plasma cells |
| Q24675355 | The potential role of human endogenous retrovirus K10 in the pathogenesis of rheumatoid arthritis: a preliminary study |
| Q30317136 | The retrovirus/superantigen hypothesis of multiple sclerosis |
| Q42456648 | The search for infectious causes of human cancers: where and why (Nobel lecture). |
| Q42459211 | The search for infectious causes of human cancers: where and why. |
| Q28660380 | The virome in mammalian physiology and disease |
| Q40258726 | Transactivation of elements in the human endogenous retrovirus W family by viral infection |
| Q54216669 | Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development. |
| Q39928233 | Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells |
Search more.